Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Subclinical volume overload in stable outpatients with chronic heart failure.

Boonen L, Verbrugge FH, Nijst P, Noyens P, De Vusser P, Verhaert D, Van Lierde J, Vrolix M, Dupont M, Mullens W.

Acta Cardiol. 2016 Jun;71(3):299-307. doi: 10.2143/AC.71.3.3152090. No abstract available.

PMID:
27594125
2.

Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead.

Ströker E, de Asmundis C, Vanduynhoven P, De Vadder K, De Vusser P, Mullens W, Chierchia GB, Brugada P, Czapla J, La Meir M, Wellens F, Van Herendael H, Rivero-Ayerza M.

Am J Cardiol. 2016 Mar 1;117(5):807-12. doi: 10.1016/j.amjcard.2015.12.013. Epub 2015 Dec 13.

PMID:
26762730
3.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

4.

Increased cardiovascular risk in patients with rheumatoid arthritis: an overview.

Puttevils D, De Vusser P, Geusens P, Dens J.

Acta Cardiol. 2014 Apr;69(2):111-8. Review.

PMID:
24783461
5.

Asymptomatic episodes of device-registered atrial tachyarrhythmia are not associated with worse cardiac resynchronization therapy response.

Verbrugge FH, Nijst P, Van Herendael H, De Vusser P, Jacobs L, Vercammen J, Verhaert D, Vandervoort P, Dupont M, Mullens W, Rivero-Ayerza M.

Europace. 2014 Aug;16(8):1197-204. doi: 10.1093/europace/eut434. Epub 2014 Jan 31.

PMID:
24489074
6.

Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy.

Verbrugge FH, Verhaert D, Grieten L, Dupont M, Rivero-Ayerza M, De Vusser P, Van Herendael H, Reyskens R, Vandervoort P, Tang WH, Mullens W.

Europace. 2013 Dec;15(12):1747-56. doi: 10.1093/europace/eut130. Epub 2013 Jul 2.

PMID:
23821473
7.

Cardiac resynchronization therapy with or without defibrillator: experience from a high-volume Belgian implantation centre.

Verbrugge FH, De Vusser P, Rivero-Ayerza M, Van Herendael H, Rondelez K, Dupont M, Vrolix M, Van Kerrebroeck C, Verhaert D, Vandervoort P, Mullens W.

Acta Cardiol. 2013 Feb;68(1):37-45.

PMID:
23457908
8.

Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.

Verbrugge FH, Dupont M, Rivero-Ayerza M, de Vusser P, Van Herendael H, Vercammen J, Jacobs L, Verhaert D, Vandervoort P, Tang WH, Mullens W.

J Card Fail. 2012 Nov;18(11):845-53. doi: 10.1016/j.cardfail.2012.09.003.

PMID:
23141857
9.

Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians.

Verbrugge FH, Dupont M, De Vusser P, Rivero-Ayerza M, Van Herendael H, Vercammen J, Jacobs L, Verhaert D, Vandervoort P, Tang WH, Mullens W.

Eur J Heart Fail. 2013 Feb;15(2):203-10. doi: 10.1093/eurjhf/hfs151. Epub 2012 Sep 20.

10.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

11.

Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy.

Mullens W, Kepa J, De Vusser P, Vercammen J, Rivero-Ayerza M, Wagner P, Dens J, Vrolix M, Vandervoort P, Tang WH.

Am J Cardiol. 2011 Aug 1;108(3):409-15. doi: 10.1016/j.amjcard.2011.03.060. Epub 2011 May 6.

PMID:
21550578
12.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

13.

No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.

de Voogt W, van Hemel N, de Vusser P, Mairesse GH, van Mechelen R, Koistinen J, van den Bos A, Roose I, Voitk J, Yli-Mäyry S, Stockman D, El Allaf D, Tse HF, Lau CP.

Europace. 2007 Sep;9(9):798-804. Epub 2007 Aug 1.

PMID:
17670782
14.

Multiple exercise induced syncopal episodes in a young woman due to arrhythmogenic right ventricular dysplasia.

Mullens W, Pison L, Vandervoort P, Eerdekens J, De Vusser P.

Europace. 2005 Mar;7(2):154-7.

PMID:
15763530
15.

Apical ballooning in relatives.

Pison L, De Vusser P, Mullens W.

Heart. 2004 Dec;90(12):e67.

16.

Radiofrequency ablation of atrioventricular node reentrant tachycardia: experience in 302 patients.

Fenelon G, Elvas L, D'avila A, Tsakonas K, Malacky T, Manios E, Geelen P, Declerck L, Ramchurn H, De Vusser P, et al.

Acta Cardiol. 1995;50(6):397-410.

PMID:
8932562
17.

Liver cirrhosis, ascites, and peripheral vascular resistance.

De Vusser P, Bounameaux H, Verhaeghe R, De Groote J.

Lancet. 1985 Nov 9;2(8463):1078. No abstract available.

PMID:
2865564

Supplemental Content

Loading ...
Support Center